Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder
Globe Newswire•06/08/2026•08:30 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.